K-Pio-Gm Tablet ER
By K-Pio-Gm
Rx
15 Tablet ER in a Strip

Composition
Glimepiride(2mg) + Metformin(500mg) + Pioglitazone(15mg)

Manufacturer - Blue Cross Laboratories Ltd
Peninsula Chambers, Peninsula Corporate Park, G.K Marg, Lower Parel (West), Mumbai - 400013, Maharashtra, INDIA.

Expires on or after
May, 2026

liver
K-Pio-Gm Tablet ER should be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of K-Pio-Gm Tablet ER in such cases, therefore, it is important to seek advice from your doctor before starting or continuing with the medication. It is advised not to use K-Pio-Gm Tablet ER in patients with severe liver disease. Always consult your healthcare provider for proper guidance when considering the use of this medication.

kidney
K-Pio-Gm Tablet ER should be used with caution in patients with kidney disease. Dose adjustment may be needed, and it is not recommended for severe kidney disease. Regular monitoring of kidney function is advised during the treatment. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking K-Pio-Gm Tablet ER.

driving
When using K-Pio-Gm Tablet ER, avoid driving if you experience symptoms of low or high blood sugar. These symptoms can affect your focus and reaction time while driving.

pregnancy
K-Pio-Gm Tablet ER may not be safe during pregnancy. Animal studies indicate potential harm to the baby. Your doctor will assess benefits versus risks before prescribing. Kindly consult your doctor.

breastfeeding
K-Pio-Gm Tablet ER is likely unsafe while breastfeeding. Limited data indicate potential harm to the baby through breastmilk exposure.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹125
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024